Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles
暂无分享,去创建一个
Judith Klein-Seetharaman | Oznur Tastan | Naveena Yanamala | Narasimhan J. Venkatachari | Velpandi Ayyavoo | O. Tastan | J. Klein-Seetharaman | R. Montelaro | A. Srinivasan | N. Yanamala | V. Ayyavoo | Narasimhan J Venkatachari | Leah A Walker | Thien Le | Timothy M Dempsey | Yaming Li | Alagarsamy Srinivasan | Ronald C Montelaro | L. Walker | Yaming Li | T. Le | T. M. Dempsey | Oznur Tastan
[1] M. Nowak,et al. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo , 1998, Nature Medicine.
[2] Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection. , 2001, Virology.
[3] R. Murali,et al. Functional Role of Residues Corresponding to Helical Domain II (Amino Acids 35 to 46) of Human Immunodeficiency Virus Type 1 Vpr , 2000, Journal of Virology.
[4] E. Freed,et al. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection , 1995, Journal of virology.
[5] S. Mahalingam,et al. The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. , 1995, Virology.
[6] Narasimhan J. Venkatachari,et al. HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). , 2009, Current HIV research.
[7] S. Benichou,et al. The Vpr protein from HIV-1: distinct roles along the viral life cycle , 2005, Retrovirology.
[8] B. Roques,et al. NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. , 2002, European journal of biochemistry.
[9] V. Planelles,et al. The role of Vpr in HIV-1 pathogenesis. , 2005, Current HIV research.
[10] N. Ahmad,et al. Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission. , 2001, AIDS research and human retroviruses.
[11] I. Chen,et al. Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA , 2003, Journal of Virology.
[12] H. Müller-Hermelink,et al. Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus , 1993, Journal of virology.
[13] A. Riva,et al. Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients , 2006, AIDS.
[14] Sergey Lyskov,et al. The RosettaDock server for local protein–protein docking , 2008, Nucleic Acids Res..
[15] Stephen R. Comeau,et al. Predicting oligomeric assemblies: N-mers a primer. , 2005, Journal of structural biology.
[16] M. Lenardo,et al. Vpr Cytopathicity Independent of G2/M Cell Cycle Arrest in Human Immunodeficiency Virus Type 1-Infected CD4+ T Cells , 2007, Journal of Virology.
[17] Simon C Watkins,et al. Corrigendum to “Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues in Vpr-mediated transactivation and virus replication” [Virology 328 (2004) 89–100] , 2005 .
[18] R. Connor,et al. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.
[19] W. Greene,et al. Slipping through the door: HIV entry into the nucleus. , 2002, Microbes and infection.
[20] F. Kirchhoff,et al. Proline 35 of Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Regulates the Integrity of the N-Terminal Helix and the Incorporation of Vpr into Virus Particles and Supports the Replication of R5-Tropic HIV-1 in Human Lymphoid Tissue Ex Vivo , 2007, Journal of Virology.
[21] Stephen R Comeau,et al. Performance of the first protein docking server ClusPro in CAPRI rounds 3–5 , 2005, Proteins.
[22] Simon C Watkins,et al. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication. , 2004, Virology.
[23] C. Chappey,et al. Maintenance of an Intact Human Immunodeficiency Virus Type 1 vpr Gene following Mother-to-Infant Transmission , 1998, Journal of Virology.
[24] D. Weiner,et al. Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr , 1997, Journal of virology.
[25] A. Badley,et al. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.
[26] N. Saksena,et al. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. , 1996, Virology.
[27] Wesley I. Sundquist,et al. Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag , 2001, Journal of Virology.
[28] B. Roques,et al. The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. , 2005, The Biochemical journal.
[29] W. Paxton,et al. Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.
[30] O. Narayan,et al. Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. , 1994, The Journal of biological chemistry.
[31] S. Mahalingam,et al. Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. , 1995, Virology.
[32] É. Cohen,et al. Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor* , 1999, The Journal of Biological Chemistry.
[33] B. Roques,et al. NMR structure of the HIV-1 regulatory protein VPR. , 2003, Journal of molecular biology.
[34] H. Göttlinger,et al. Isolation of Human Immunodeficiency Virus Type 1 Cores: Retention of Vpr in the Absence of p6gag , 2000, Journal of Virology.
[35] K. Khalili,et al. Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[36] D. Birx,et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus , 1995, Journal of virology.
[37] F. Boisvert,et al. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation , 1995, Journal of virology.
[38] É. Cohen,et al. Human Immunodeficiency Virus Type 1 Vpr Is a Positive Regulator of Viral Transcription and Infectivity in Primary Human Macrophages , 1998, The Journal of experimental medicine.
[39] U. Schubert,et al. Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells , 2000, Journal of Virology.
[40] Barbara Imperiali,et al. Protein oligomerization: how and why. , 2005, Bioorganic & medicinal chemistry.
[41] I. Chen,et al. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. , 1998, Science.
[42] M. Kamata,et al. Novel Nuclear Import of Vpr Promoted by Importin α Is Crucial for Human Immunodeficiency Virus Type 1 Replication in Macrophages , 2007, Journal of Virology.
[43] Ling-jun Zhao,et al. Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion , 2004, Retrovirology.
[44] J. Darlix,et al. Direct Vpr-Vpr Interaction in Cells monitored by two Photon Fluorescence Correlation Spectroscopy and Fluorescence Lifetime Imaging , 2008, Retrovirology.
[45] H. Ariga,et al. The Role of Vpr in the Regulation of HIV-1 Gene Expression , 2006, Cell cycle.
[46] Michael Emerman,et al. HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.
[47] J. Sodroski,et al. Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.
[48] M. Kamata,et al. Virion-Associated Vpr of Human Immunodeficiency Virus Type 1 Triggers Activation of Apoptotic Events and Enhances Fas-Induced Apoptosis in Human T Cells , 2009, Journal of Virology.
[49] J. D. De Mey,et al. HIV-1 Vpr Oligomerization but Not That of Gag Directs the Interaction between Vpr and Gag , 2009, Journal of Virology.
[50] Sandor Vajda,et al. ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..
[51] Simon C Watkins,et al. Distinct Intracellular Trafficking of Equine Infectious Anemia Virus and Human Immunodeficiency Virus Type 1 Gag during Viral Assembly and Budding Revealed by Bimolecular Fluorescence Complementation Assays , 2007, Journal of Virology.
[52] Victoria A. Roberts,et al. Surveying molecular interactions with DOT , 1995 .
[53] L. T. Ten Eyck,et al. Protein docking using continuum electrostatics and geometric fit. , 2001, Protein engineering.